In CAPS patients, impaired NLRP3/cryopyrin results in excessive release of the active form of interleukin (IL)-1β [7], causing severe inflammatory symptoms including fever, rash, conjunctivitis, headache, arthralgia/arthritis and fatigue [8]. This evidence concerns the gene NLRP3 and cryopyrin-associated periodic syndrome.